Multi-Center, Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of Primary Vaccination With NBP606 in Healthy Infants

Trial Profile

Multi-Center, Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of Primary Vaccination With NBP606 in Healthy Infants

Recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs NBP 606 (Primary) ; Pneumococcal vaccine
  • Indications Bacterial infections
  • Focus Therapeutic Use
  • Sponsors SK Chemicals
  • Most Recent Events

    • 21 Jun 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jun 2016.
    • 21 Jun 2016 Planned End Date changed from 1 Jul 2015 to 1 Dec 2016.
    • 21 Jun 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top